The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

WIN Metals (ASX:WIN) is at the RIU Explorers Conference in Fremantle this week, talking with investors about its value proposition.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

It has a market cap below $10 million, despite having a 357,000-ounce indicated and inferred gold resource, plus nickel and lithium resources – also in WA – which it holds for when the value of these commodities picks up.

HotCopper’s Sonia Madigan spoke with MD Steve Norregaard From the Floor.

WIN last traded at 1.8cps after adding 5.88% in value early today.

Join the discussion. See what HotCopper users are saying about WIN Metals and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

win by the numbers
More From The Market Online
US flag

Dateline Resources pops +40% on Trump gov’t move to greenlight REE and gold mining

An injunction on ASX-listed Dateline Resources’ (ASX:DTR) California-based Colosseum REE and gold project appears set to be lifted after
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

ASX Today: XJO has a good day ahead of RBA rate call; AU bond sell-off continues

While we’re set to get the RBA’s next rate decision tomorrow – which all big bank analysts think is going to be a
Aussie cash

Northern Star jumps +7% on confirmed takeover rumour from Gold Fields Ltd

ASX-listed Northern Star Resources (ASX:NST) has confirmed reports in Bloomberg that it’s received a 100% takeover offer from a

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)